Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) for its Coronary Intravascular Lithotripsy (IVL) System to ...
A new study found that cannabis users under the age of 50 are about 6.2 times more likely to experience a heart attack than ...
Most people probably would not connect seasonal allergies with their hearts. Itchy, watery eyes and stuffy noses, sure—but ...
People with intermediate-risk scores on coronary artery calcium testing who received statins and intensive health coaching ...
Opens in a new tab or window Equipped with knowledge of their coronary artery calcium (CAC) scan results and a statin prescription, patients were more likely to slow their plaque progression over ...
Stamford, Connecticut Wednesday, March 12, 2025, 15:00 Hrs [IST] ...
John Baker, MD, cardiologist with West Tennessee Medical Group, recently performed the first procedure using the AGENT™ ...
While classic symptoms like chest pain are well-known, there are more surprising heart disease symptoms you need to pay ...
Medical Device Network on MSN13d
FDA clears Caristo’s AI-powered CAD diagnostic softwareThe software can determine the extent and severity of coronary plaque build-up implicated in coronary artery disease.
When it comes to your child's health, do you think much about their risks of developing heart disease? Probably not, since so ...
Critics say a new, broader definition of high-risk plaque opens the door to more tests, diagnoses, and invasive procedures, steering us down a potentially harmful path.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback